1. Home
  2. Analysis
  3. Keppra
  4. Accutane

Keppra and Accutane drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Keppra and Accutane. Common interactions include pulmonary embolism among females and inflammatory bowel disease among males.

The phase IV clinical study analyzes what interactions people who take Keppra and Accutane have. It is created by eHealthMe based on reports of 36 people who take Keppra and Accutane from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 02, 2023

36 people who take Keppra and Accutane together, and have interactions are studied.

What is Keppra?

Keppra has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 66,560 Keppra users for its effectiveness, alternative drugs and more.

What is Accutane?

Accutane has active ingredients of isotretinoin. It is often used in acne. eHealthMe is studying from 33,664 Accutane users for its effectiveness, alternative drugs and more.

Number of Keppra and Accutane reports submitted per year:

Keppra and Accutane drug interactions.

Common Keppra and Accutane drug interactions by gender *:

female:

  1. Pulmonary embolism
  2. Abdominal adhesions
  3. Anal fissure
  4. Bronchitis
  5. Colitis
  6. Convulsion
  7. Dizziness
  8. Head injury
  9. Headache
  10. Joint swelling

male:

  1. Inflammatory bowel disease
  2. Colitis ulcerative
  3. Arthralgia
  4. Arthritis
  5. Asthenia
  6. Blood glucose decreased
  7. Blood lactate dehydrogenase increased
  8. Blood uric acid decreased
  9. Bone marrow failure
  10. Cerebral disorder

Common Keppra and Accutane drug interactions by age *:

0-1:

n/a

2-9:

  1. Colitis ulcerative
  2. Depression
  3. Inflammatory bowel disease
  4. Abdominal adhesions
  5. Bronchitis
  6. Convulsion
  7. Crohn's disease
  8. Deep vein thrombosis
  9. Gastrointestinal injury
  10. Injury

10-19:

  1. Cerebral disorder

20-29:

  1. Oral discomfort
  2. Rash
  3. Rhinorrhoea
  4. Sinusitis
  5. Tremor
  6. Visual field defect
  7. Vomiting
  8. Weight decreased
  9. Xeroderma
  10. Emotional distress

30-39:

  1. Anal fissure
  2. Depression
  3. Inflammatory bowel disease
  4. Suicidal ideation
  5. Abortion spontaneous
  6. Clostridium difficile colitis
  7. Colitis ulcerative
  8. Crohn's disease
  9. Deep vein thrombosis
  10. Intestinal obstruction

40-49:

  1. Alopecia
  2. Arthralgia
  3. Blood cholesterol increased
  4. Blood triglycerides increased
  5. Cholelithiasis
  6. Colitis
  7. Colitis ulcerative
  8. Depression
  9. Dizziness
  10. Fall

50-59:

  1. Crohn's disease
  2. Death
  3. Inflammatory bowel disease
  4. Intestinal stenosis
  5. Glioblastoma multiforme
  6. Haematuria
  7. Hypertonic bladder
  8. Urge incontinence

60+:

  1. Inflammatory bowel disease
  2. Colitis ulcerative
  3. Blood triglycerides increased
  4. Cheilitis
  5. Cholestasis
  6. Crohn's disease
  7. Cytolytic hepatitis
  8. Dermatitis
  9. Hyperhidrosis
  10. Lip dry

Common conditions people have *:

  1. Brain Neoplasm Malignant (brain cancer tumour): 7 people, 19.44%
  2. Acne Cystic (skin problems that cause pimples): 3 people, 8.33%
  3. Temporal Lobe Epilepsy (a term that refers to a condition where seizures are generated in the portion of the brain called the temporal lobe): 2 people, 5.56%
  4. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 5.56%
  5. Growth Hormone Deficiency: 2 people, 5.56%
  6. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 2 people, 5.56%
  7. Birth Control: 2 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Keppra and Accutane?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Common Keppra and Accutane interactions:

Browse all drug interactions of Keppra and Accutane:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Keppra side effects:

Browse all side effects of Keppra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Accutane side effects:

Browse all side effects of Accutane:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Keppra interactions:

Browse all interactions between Keppra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Accutane interactions:

Browse all interactions between Accutane and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on levetiracetam and isotretinoin (the active ingredients of Keppra and Accutane, respectively), and Keppra and Accutane (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Keppra and Accutane.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.